Kewaunee Scientific Corp (KEQU)
Commercial and Professional Services • Industrial Goods
Financial Metrics
Price to Earnings10.81x
Revenue Growth (1Y)17.27%
Debt to Equity0.32x
Strengths
Valuation
Kewaunee Scientific Corp is undervalued
News
All
Press Releases
News
Filings

June 26, 202610-K Annual Report for 2026 FY

June 23, 2026 Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter

June 10, 2026 Kewaunee Scientific to Report Results for Fiscal Year and Fourth Quarter

April 14, 2026 Kewaunee Scientific Corporation Appoints Jorge Santos as Vice President of International Sales, Laboratory Products Group

March 13, 202610-Q Quarterly Report for 2026 Q3

March 11, 2026 Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2026

March 03, 2026 Kewaunee Scientific and Nu Aire Inc. to Attend analytica 2026 in Munich

February 25, 2026 Kewaunee Scientific to Report Results for Third Quarter Fiscal Year 2026

January 08, 2026President Of Kewaunee Scientific Makes $81K Sale

December 12, 202510-Q Quarterly Report for 2026 Q2

December 10, 2025 Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2026

December 04, 2025 Kewaunee Scientific Announces Successful Debt Refinancing and Full Repayment of Seller Notes From the Company's Acquisition of Nu Aire, Inc.

November 26, 2025 Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2026

October 10, 2025Donald T. Gardner III Executes Sell Order: Offloads $128K In Kewaunee Scientific Stock

October 01, 2025Kewaunee Scientific President Sold $80K In Company Stock

September 25, 2025Insider Selling: DAVID THOMAS HULL III Unloads $75K Of Kewaunee Scientific Stock

September 23, 2025Insider Decision: DAVID THOMAS HULL III Offloads $65K Worth Of Kewaunee Scientific Stock

September 12, 202510-Q Quarterly Report for 2026 Q1

September 11, 2025 Kewaunee Scientific Announces Appointment of J. Jette Campbell to Board of Directors

September 10, 2025 Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2026

September 02, 2025 Kewaunee Scientific to Attend the 2025 Arablab Live Trade Show in Dubai

August 27, 2025 Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2026

July 29, 2025Donald T. Gardner III Implements A Sell Strategy: Offloads $175K In Kewaunee Scientific Stock

July 02, 202510-K Annual Report for 2025 FY

June 25, 2025 Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter

June 11, 2025 Kewaunee Scientific to Report Results for Fiscal Year and Fourth Quarter

April 15, 2025DAVID THOMAS HULL III Implements A Sell Strategy: Offloads $59K In Kewaunee Scientific Stock

April 11, 2025Kewaunee Scientific Chief Financial Officer Sold $148K In Company Stock

March 14, 202510-Q Quarterly Report for 2025 Q3

March 12, 2025 Kewaunee Scientific Announces Amendment to Share Repurchase Program

March 12, 2025 Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2025

February 26, 2025 Kewaunee Scientific to Report Results for Third Quarter Fiscal Year 2025

December 13, 202410-Q Quarterly Report for 2025 Q2

December 11, 2024 Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2025

November 27, 2024 Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2025

November 01, 2024 Kewaunee Scientific Corporation Completes Acquisition of Nu Aire

September 17, 2024Kaskela Law LLC Announces Shareholder Investigation of Kewaunee Scientific Corp. (NASDAQ: KEQU) and Encourages Investors to Contact the Firm

September 13, 202410-Q Quarterly Report for 2025 Q1

September 11, 2024 Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2025

September 04, 2024 Kewaunee Scientific Corporation Announces Attendance at the 2024 Arablab Live Tradeshow and Conference

August 28, 2024 Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2025

August 07, 2024KEQU Investors Have Opportunity to Join Kewaunee Scientific Corporation Fraud Investigation with the Schall Law Firm

June 28, 202410-K Annual Report for 2024 FY

June 26, 2024 Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter

June 12, 2024 Kewaunee Scientific to Report Results for Fiscal Year and Fourth Quarter

March 08, 202410-Q Quarterly Report for 2024 Q3

March 06, 2024 Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2024

February 21, 2024 Kewaunee Scientific to Report Results for Third Quarter Fiscal Year 2024

December 08, 202310-Q Quarterly Report for 2024 Q2

September 01, 202310-Q Quarterly Report for 2024 Q1

June 30, 202310-K Annual Report for 2023 FY

March 10, 202310-Q Quarterly Report for 2023 Q3

December 09, 202210-Q Quarterly Report for 2023 Q2

September 09, 202210-Q Quarterly Report for 2023 Q1

July 01, 202210-K Annual Report for 2021 FY

March 11, 202210-Q Quarterly Report for 2021 Q3

December 17, 202110-Q Quarterly Report for 2021 Q2

September 10, 202110-Q Quarterly Report for 2021 Q1
A. Company Overview
Kewaunee Scientific Corporation, established in 1906 and incorporated in Michigan in 1941, operates within the design, manufacture, and installation sectors of laboratory, healthcare, and technical furniture and infrastructure products. Initially publicly held in 1968, the company was reincorporated in Delaware in 1970. Kewaunee Scientific is recognized for its comprehensive offerings, which include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, as well as epoxy resin work surfaces and sinks.
The products of Kewaunee are primarily marketed through purchase orders and contracts via associated dealers, along with the company’s subsidiary operations in Singapore and India. Furthermore, a national distributor plays a crucial role in the sales strategy. The company predominantly caters to various industries, including pharmaceuticals, biotechnology, industrial sectors, chemical and commercial research laboratories, educational institutions, healthcare facilities, governmental entities, and manufacturing plants.
Kewaunee's operational landscape is characterized by intense competition, with a considerable proportion of business derived from competitive public bidding processes. The necessity for advance planning is often evident, as laboratory and healthcare furniture orders may require delivery dates set far in the future, correlated with ongoing construction projects. Consequently, delays in construction can adversely affect order fulfillment timelines.
B. Products and Services
Kewaunee Scientific's product portfolio is tailored to the needs of specific markets. Its array of products can be categorized as follows:
- Casework Solutions: This includes steel and wood casework designed for laboratory and healthcare environments.
- Fume Hoods: Essential for laboratories requiring proper ventilation to manage hazardous fumes.
- Modular Systems: Adaptable designs that offer flexibility in laboratory configurations.
- Moveable Workstations: Workspaces that can be easily relocated to accommodate different project demands.
- Benches: Stand-alone benches which can be customized for various laboratory tasks.
- Biological Safety Cabinets: Critical for environments that require protection from biological hazards.
- Epoxy Resin Surfaces: Durable and chemical-resistant surfaces designed for laboratory work environments.
These products are crafted from raw materials such as cold-rolled carbon steel, stainless steel, hardwood lumber, and plywood, among others, which are procured from multiple suppliers to ensure consistent availability.
C. Market Dynamics and Financial Considerations
The market in which Kewaunee operates is highly competitive, influenced predominantly by pricing, product performance, and customer service. Revenues are significantly impacted by the ability to secure contracts through public bids, making the effective management of relationships with major customers critical. Sales derived from two domestic dealers and a national distributor represented approximately 42% and 35% of the Company’s sales in fiscal years 2024 and 2023, respectively. Any loss of sales from these significant accounts would materially affect financial results.
The company faces unique financial dynamics due to the nature of its product installations, often tied to construction projects where payment for products is received over extended periods. Payment terms may include retention amounts, both of which necessitate a robust working capital strategy.
By its assessment, the order backlog amounts to $155.6 million as of April 30, 2024, which indicates a solid pipeline of future revenues, contingent upon the timely fulfillment of orders and dependencies on customer schedules and construction timelines.
D. Research and Development
Kewaunee invests significantly in research and experimentation to innovate and redesign products, reflecting its commitment to maintaining a competitive edge. In the fiscal year ending April 2024, the company expensed $920,000 on these initiatives, compared to $1,012,000 in the previous year.
E. Competition
The competitive landscape is shaped by various players offering similar products and services. Key competitive factors include price, product performance, and the quality of customer support. The fact that much of the business revolves around public bidding accentuates the need for Kewaunee to consistently present compelling value propositions to secure contracts.
Stock Infos
SectorIndustrial Goods
IndustryCommercial and Professional Services
CEOThomas D. Hull Iii
Dividends

Furniture
Kewaunee Scientific Corporation specializes in designing and manufacturing laboratory, healthcare, and technical furniture products, including steel and wood casework, fume hoods, and other modular system applications.

Biotechnology
The company provides specialized products like biological safety cabinets that are essential for laboratories in the biotechnology sector, ensuring safe environments for handling biological materials.

Pharmaceutical Companies
Kewaunee's products cater to the pharmaceutical industry, particularly through their laboratory furniture solutions, which support research and development activities in pharmaceuticals.

Healthcare Services & Hospitals
With a focus on healthcare facilities, Kewaunee manufactures furniture and infrastructure necessary for laboratory support in hospitals and clinical settings.

Industry Complexity
The laboratory equipment and furniture industry involves specific regulations, standards, and technical knowledge, creating high barriers to entry for new competitors. Kewaunee's established reputation and expertise in navigating these complexities give it an advantage over potential entrants.